LONDON (Reuters) – An experimental vaccine developed by AstraZeneca and the University of Oxford against the new coronavirus produced an immune response in early-stage clinical trials, data showed on Monday, preserving hope that it could be in use by the end of the year. Called AZD1222, the vaccine has been …
Read More »
LONDON (Reuters) – An experimental coronavirus vaccine developed by AstraZeneca and the University of Oxford was safe and produced an immune response in early-stage clinical trials, the data showed on Monday, keeping alive the hope that it might be in use. for the end of the year . FILE PHOTO: …
Read More »
(Reuters) – Synairgen Plc (SYNG.L) said Monday that his drug helped reduce the risk of serious cases in hospitalized patients with COVID-19, according to data from a trial of more than 100 people in the UK, which triggered his actions. The trial, which used interferon beta, showed that patients who …
Read More »
(Reuters) – The following is a brief summary of some of the latest scientific studies on the new coronavirus and efforts to find treatments and vaccines for COVID-19, the disease caused by the virus. FILE PHOTO: A computer image created by Nexu Science Communication in conjunction with Trinity College in …
Read More »
LONDON / OTTAWA (Reuters) – Russian state-backed hackers are trying to steal COVID-19 vaccine research and treatment from academic and pharmaceutical institutions around the world, the National Center for Cyber Security said Thursday. (NCSC) of Great Britain. A coordinated statement by Britain, the United States and Canada attributed the attacks …
Read More »